Jan 10, 2019 | News, Uncategorized
Amylon Therapeutics announces seed investment round, focus on CNS disorders Key updates Amylon Therapeutics B.V. is a spin-off company from ProQR Therapeutics N.V., a NASDAQ listed biopharmaceutical company based in Leiden, the Netherlands. Amylon announces the...
Recent Comments